01.04.2024 17:05:00 - dpa-AFX: *VERTEX ANNOUNCES NEW DRUG SUBMISSION FOR EXAGAMGLOGENE AUTOTEMCEL ACCEPTED FOR PRIORITY REVIEW BY HEALTH CANADA

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Vertex Pharmaceuticals 882807 NASDAQ 454,570 31.05.24 21:39:09 +11,520 +2,60% 454,180 454,760 444,740 443,050

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH